Treace Medical Concepts, Inc. (TMCI)
NGS · Common · CUSIP 89455T109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TMCI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
89455T109
IPO
4/23/2021 · $17.00/share
Business: Treace Medical Concepts, Inc. is a medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly.

Company Contact

CEO
John T. Treace
CFO
Mark L. Hair
Headquarters
203 Fort Wade Rd., Suite 150, Ponte Vedra, FL 32081
Phone
904-373-5940
Investor Relations
Mark L. Hair · 904-373-5940 · mhair@treace.net
General Email
IR@treace.net
Email Form
Contact Form »
SEC EDGAR Filings
View filings »